Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors

被引：0
|
作者：
Iris Y. Sheng
Shilpa Gupta
Chandana A. Reddy
Dana Angelini
Pauline Funchain
Tamara A. Sussman
Joseph Sleiman
Moshe C. Ornstein
Keith McCrae
Alok A. Khorana
机构：
[1] Beth Israel Lahey Mt. Auburn Hospital,Department of Medicine
[2] Cleveland Clinic Taussig Cancer Institute,Department of Hematology and Medical Oncology
[3] Cleveland Clinic Taussig Cancer Institute,Department of Radiation Oncology
[4] Department of Medical Oncology,Department of Gastroenterology
[5] Dana Farber Cancer Institute,undefined
[6] University of Pittsburgh Medical Center,undefined
来源：
Targeted Oncology | 2022年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：563 / 569
页数：6
相关论文
共 50 条
  • [21] Treatment of Urothelial Cancer in Elderly Patients: Focus on Immune Checkpoint Inhibitors
    Gray Jodon
    Stacy M. Fischer
    Elizabeth R. Kessler
    Drugs & Aging, 2018, 35 : 409 - 421
  • [22] Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
    Maiorano, Brigida Anna
    Di Maio, Massimo
    Cerbone, Linda
    Maiello, Evaristo
    Procopio, Giuseppe
    Roviello, Giandomenico
    JAMA NETWORK OPEN, 2024, 7 (03) : E241215
  • [23] Immune checkpoint inhibitors: risk of venous thromboembolism in cancer patients examined
    Reactions Weekly, 2023, 1960 (1) : 12 - 12
  • [24] The value of performance status in predicting venous thromboembolism in lung cancer patients treated with immune checkpoint inhibitors
    Zhang, Jiarui
    Yang, Linhui
    Tian, Huohuan
    Xu, Rui
    Liu, Dan
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2024, 69
  • [25] Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitors
    Kartolo, Adi
    Yeung, Cynthia
    Moffat, Gordon T.
    Hanna, Lilian
    Hopman, Wilma
    Baetz, Tara
    IMMUNOTHERAPY, 2022, 14 (01) : 23 - 30
  • [26] Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sanda, Gregory E.
    Shabto, Julie M.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Yantorni, Lauren B.
    Russler, Greta Anne
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Kissick, Haydn
    Ogan, Kenneth
    Master, Viraj A.
    Carthon, Bradley C.
    Kucuk, Omer
    Bilen, Mehmet Asim
    ONCOLOGIST, 2023, : 1072 - 1078
  • [27] Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
    Meynard, Lucie
    Dinart, Derek
    Delaunay, Blandine
    Flechon, Aude
    Saldana, Carolina
    Lefort, Felix
    Gravis, Gwenaelle
    Thiery-Vuillemin, Antoine
    Cancel, Mathilde
    Coquan, Elodie
    Ladoire, Sylvain
    Maillet, Denis
    Rolland, Frederic
    Boughalem, Elouen
    Martin, Sophie
    Laramas, Mathieu
    Crouzet, Laurence
    Abbar, Baptiste
    Falkowski, Sabrina
    Pouessel, Damien
    Roubaud, Guilhem
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : 43 - 53
  • [28] New Settings for Immune Checkpoint Inhibitors in Urothelial Cancer
    Siefker-Radtke, Arlene O.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 629 - 632
  • [29] Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition
    Lam, Jie M.
    Liu, Wing K.
    Powles, Thomas
    Tang, Yen Zhi
    Szabados, Bernadett
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (04): : 659 - 662
  • [30] Nephrotoxicity in patients with cancer treated with immune checkpoint inhibitors.
    Papaiakovou, Evangelos Eleutherakis
    Kastritis, Efstathios
    Zagouri, Flora
    Grapsa, Dimitra
    Ntanassis-Stathopoulos, Ioannis
    Stefanou, Dimitra
    Evangelou, Georgios
    Kotteas, Ilias
    Dimopoulos, Meletios A.
    Syrigos, Konstantinos
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345